Literature DB >> 33913413

Sudden hearing loss and coronavirus disease 2019: the role of corticosteroid intra-tympanic injection in hearing improvement.

V Rahimi1, M K Asiyabar2, N Rouhbakhsh1.   

Abstract

BACKGROUND: Coronavirus disease 2019 was first seen in December 2019. Due to the insidious and complex nature of the disease, the list of symptoms is rapidly expanding. So far, few studies have reported sudden sensorineural hearing loss as a possible symptom of coronavirus disease 2019. CASE REPORT: A 60-year-old woman with a complaint of sudden sensorineural hearing loss and subjective severe tinnitus presented to the ENT clinic. Coronavirus disease 2019 was subsequently confirmed with a polymerase chain reaction test. At the time of presentation, she was treated with intra-tympanic dexamethasone. Improvements in hearing threshold and speech perception, and a subjective reduction in tinnitus, were observed after treatment.
CONCLUSION: This case report supports evidence from other case reports of a possible association between coronavirus disease 2019 and sudden sensorineural hearing loss. Sudden sensorineural hearing loss may be a symptom of this disease that behaves as an underlying aggravating factor. Intra-tympanic injection of corticosteroids is recommended for managing these patients during the pandemic.

Entities:  

Keywords:  COVID-19; Coronavirus; Corticosteroid; Sensorineural Hearing Loss

Year:  2021        PMID: 33913413     DOI: 10.1017/S0022215121001080

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  COVID-19 and Sudden Sensorineural Hearing Loss: A Systematic Review.

Authors:  Xiangming Meng; Jing Wang; Jian Sun; Kangxu Zhu
Journal:  Front Neurol       Date:  2022-04-28       Impact factor: 4.003

2.  Slight High-Frequency Hearing Loss, Effect of COVID-19 or Hydroxychloroquine Usage?

Authors:  Vida Rahimi; Nematollah Rouhbakhsh; Seyed Ali Dehghan Manshadi
Journal:  Otol Neurotol       Date:  2022-08-17       Impact factor: 2.619

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.